BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26398693)

  • 1. VITREORETINAL COMPLICATIONS IN EYES WITH BOSTON KERATOPROSTHESIS TYPE I.
    Rishi P; Rishi E; Koundanya VV; Mathur G; Iyer G; Srinivasan B
    Retina; 2016 Mar; 36(3):603-10. PubMed ID: 26398693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitreoretinal complications of the Boston Keratoprosthesis.
    Modjtahedi BS; Eliott D
    Semin Ophthalmol; 2014; 29(5-6):338-48. PubMed ID: 25325859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posterior Segment Complications and Impact on Long-Term Visual Outcomes in Eyes With a Type 1 Boston Keratoprosthesis.
    Moshiri A; Safi M; Morse LS; Tang VD; Yiu G; Park SS; Schwab I; Li J; Mannis MJ
    Cornea; 2019 Sep; 38(9):1111-1116. PubMed ID: 31232746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitreoretinal Complications and Outcomes in 92 Eyes Undergoing Surgery for Modified Osteo-Odonto-Keratoprosthesis: A 10-Year Review.
    Rishi P; Rishi E; Agarwal V; Nair S; Iyer G; Srinivasan B; Agarwal S
    Ophthalmology; 2018 Jun; 125(6):832-841. PubMed ID: 29342438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative posterior segment complications in eyes treated with the Boston type I keratoprosthesis.
    Goldman DR; Hubschman JP; Aldave AJ; Chiang A; Huang JS; Bourges JL; Schwartz SD
    Retina; 2013 Mar; 33(3):532-41. PubMed ID: 23073339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VITREORETINAL COMPLICATIONS AFTER PENETRATING KERATOPLASTY.
    Park Y; Kim MH; Won JY; Kim HS; Park YH
    Retina; 2016 Nov; 36(11):2110-2115. PubMed ID: 27115992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
    Aldave AJ; Kamal KM; Vo RC; Yu F
    Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitreoretinal surgery for complications of choroidal tumor biopsy.
    Grixti A; Angi M; Damato BE; Jmor F; Konstantinidis L; Groenewald C; Heimann H
    Ophthalmology; 2014 Dec; 121(12):2482-8. PubMed ID: 25085629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
    Greiner MA; Li JY; Mannis MJ
    Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II Implantation.
    Lee R; Khoueir Z; Tsikata E; Chodosh J; Dohlman CH; Chen TC
    Ophthalmology; 2017 Jan; 124(1):27-35. PubMed ID: 27538795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boston Type 1 Keratoprosthesis: Visual Outcomes, Device Retention, and Complications.
    Goins KM; Kitzmann AS; Greiner MA; Kwon YH; Alward WL; Ledolter J; Wagoner MD
    Cornea; 2016 Sep; 35(9):1165-74. PubMed ID: 27191675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitreoretinal surgery in eyes with Pintucci biointegrable keratoprosthesis.
    Rishi P; Maskati QB; Ray R; Iyer GK; Srinivasan B; Pillai VS
    Retina; 2010 Feb; 30(2):287-93. PubMed ID: 19881398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure.
    Kang JJ; de la Cruz J; Cortina MS
    Cornea; 2012 Dec; 31(12):1436-40. PubMed ID: 22367042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
    Sejpal K; Yu F; Aldave AJ
    Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ULTRA-WIDEFIELD IMAGING OF POSTERIOR SEGMENT PATHOLOGY IN THE SETTING OF THE BOSTON KERATOPROSTHESIS.
    Kornberg DL; Yannuzzi NA; Klufas MA; DʼAmico DJ; Orlin A; Kiss S
    Retina; 2016 Jun; 36(6):1101-10. PubMed ID: 26536101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International results with the Boston type I keratoprosthesis.
    Aldave AJ; Sangwan VS; Basu S; Basak SK; Hovakimyan A; Gevorgyan O; Kharashi SA; Jindan MA; Tandon R; Mascarenhas J; Malyugin B; Padilla MD; Maskati Q; Agarwala N; Hutauruk J; Sharma M; Yu F
    Ophthalmology; 2012 Aug; 119(8):1530-8. PubMed ID: 22512986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitreoretinal Complications in Boston Keratoprosthesis Type 1.
    Khair D; Salimi A; Harissi-Dagher M
    Am J Ophthalmol; 2021 Nov; 231():101-108. PubMed ID: 34107311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
    Pujari S; Siddique SS; Dohlman CH; Chodosh J
    Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boston type 1 keratoprosthesis: the university of california davis experience.
    Bradley JC; Hernandez EG; Schwab IR; Mannis MJ
    Cornea; 2009 Apr; 28(3):321-7. PubMed ID: 19387235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitreoretinal aspects of permanent keratoprosthesis.
    Klufas MA; Yannuzzi NA; D'Amico DJ; Kiss S
    Surv Ophthalmol; 2015; 60(3):216-28. PubMed ID: 25890625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.